SIGN IN
2026 Summer Intern - Commercial Insights and Analytics (MBA) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Kardigan · 1 hour ago

2026 Summer Intern - Commercial Insights and Analytics (MBA)

Kardigan is a heart health company focused on making cardiovascular disease preventable and curable. As an Insights & Analytics Intern, you will support strategic decision-making through data-driven insights, working closely with cross-functional teams to assess market opportunities and inform go-to-market strategies.
Artificial Intelligence (AI)BiopharmaHealth CareMedical

Responsibilities

Conduct market research and competitive intelligence analysis to assess opportunities and threats across various therapeutic areas
Analyze patient journey data, clinical results and real-world evidence to inform marketing campaigns, go-to-market strategy and life-cycle development
Build financial models and sales forecasts to support strategic decision-making
Support ad-hoc projects, such as evaluating partnership opportunities, assessing market entry barriers for new indications or geographies, analyzing competitor actions and clinical trial results, synthesizing key insights and findings for executive presentations

Qualification

Analytical skillsMarket researchFinancial modelingHealthcare experienceMicrosoft Office SuiteCommunication skillsProblem-solving skillsTeamwork

Required

First-year MBA students enrolled full-time graduating between December 2026 and June 2027
Experience in healthcare or healthcare-adjacent finance/consulting/strategy is a plus
Strong analytical and problem-solving skills
Excellent written and verbal communication skills
Understanding of financial principles
High proficiency in Microsoft Office Suite (Excel, PowerPoint, Word)
Must be able to work in-person at SSF office for full duration of the internship
Candidates must be based in the San Francisco Bay Area (no relocation assistance)

Company

Kardigan

twittertwitter
company-logo
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.

Funding

Current Stage
Growth Stage
Total Funding
$554M
Key Investors
ARCH Venture Partners,Perceptive Advisors,Sequoia Heritage
2025-10-14Series B· $254M
2025-01-10Series A· $300M

Leadership Team

leader-logo
Brianne Jahn
Chief Financial Officer
linkedin
leader-logo
Diane Hagerty
Chief Quality Officer
linkedin
Company data provided by crunchbase